Dr. Reddy's Laboratories, Global Response Aid, and Appili Therapeutics Announce the Filing of an Application for REEQONUS™ (favipiravir) Tablets for the Treatment of COVID-19 under Health Canada’s Interim Order
December 22, 2020 01:11 AM EST (BUSINESS WIRE)
折しも本日、Dr. Reddy's、Global Response Aid、Appili Therapeuticsのコンソーシアムが、カナダ保健省にファビピラビルの暫定使用の申請を行ったとのこと。
コロナの治療薬・ワクチン用に定めたプロセスで迅速に承認手続きを進める模様。
とりあえずはカナダでの朗報に期待。
Dr. Reddy's Laboratories, Global Response Aid, and Appili Therapeutics Announce the Filing of an Application for REEQONUS™ (favipiravir) Tablets for the Treatment of COVID-19 under Health Canada’s Interim Order
December 22, 2020 01:11 AM EST (BUSINESS WIRE)